Meropenem Bausch Health

Meropenem, the active ingredient in Meropenem Bausch Health, is a carbapenem antibiotic presented as an injection solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, hospital‑acquired pneumonia and septicemia in hospitalized patients.

GNH USA supplies Meropenem Bausch Health as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meropenem is a broad‑spectrum carbapenem used for serious bacterial infections that are resistant to other agents.

- Complicated intra‑abdominal infections: provides rapid bacterial eradication in the peritoneal cavity. - Complicated urinary tract infections: achieves clearance of resistant uropathogens. - Hospital‑acquired pneumonia: treats Gram‑negative and Gram‑positive pathogens in ventilated patients. - Septicemia: rapidly reduces bloodstream bacterial load and prevents progression to shock.

Adverse reactions may occur with any intravenous antibiotic. Monitoring patients for both common and serious events is recommended.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Vomiting: occasional post‑infusion emesis. - Diarrhea: may be watery and self‑limiting. - Rash: erythematous skin eruption. - Infusion site phlebitis: pain or redness at the catheter site. - Elevated liver enzymes: transient increase in ALT/AST.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disease. - Clostridioides difficile colitis: severe diarrhea with pseudomembranous colitis. - Anaphylaxis: acute hypersensitivity requiring emergency treatment. - Severe neutropenia: marked reduction in white blood cells. - Acute renal failure: worsening kidney function during therapy. - Hypersensitivity reactions: including serum sickness‑like manifestations.

Use meropenem with caution in specific clinical situations and follow handling guidelines.

- Renal function: assess creatinine clearance and adjust dose if necessary. - Hepatic impairment: monitor liver function tests during prolonged therapy. - History of seizures: evaluate risk and consider alternative agents. - Concomitant valproic acid: increased seizure risk; monitor neurologic status. - Pregnancy: risk category unknown; prescribe only when benefits outweigh potential risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines; some combinations require avoidance while others need close monitoring.

Major Interactions (Avoid): - Valproic acid: may lower seizure threshold and increase neurotoxicity. - Cytotoxic chemotherapy agents: additive neurotoxic risk. - Probenecid: can reduce renal clearance of meropenem, raising plasma levels.

Moderate Interactions (Monitor Closely): - Loop diuretics: heightened risk of nephrotoxicity. - Aminoglycosides: potential additive renal toxicity. - Warfarin: possible alteration of INR; monitor coagulation parameters.